Cures for HIV and blurred vision and using cosmic rays to monitor nuclear waste drums are on our list of recent promising university spinouts.

CasInvent Pharma’s approach is aimed at three forms of cancer rather than just one, with leukaemia, lymphoma and solid tumours all in its sights.

Spinouts have defied the slump in the rest of the market, with deal numbers up 10% from last year. The average size of seed and series B rounds has actually increased.

Non-recyclable plastics making asphalt more sustainable and a vaccine to save the honeybee are just two of 10 inventions that caught our eye.

Could we save the environment one parcel at a time? Politecnico di Milano’s packaging technology spinout Voidless hopes so.

About half of all vaccines are wasted due to challenges surrounding cold chain logistics, so EnsiliTech aims to remove the need for cold storage.

Charbel Rizk has spun Oculi out of Johns Hopkins University to commercialise technology that gives computer vision the capabilities of the human eye.

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.